AMC Networks (AMCX) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
204
Total Shares Held
33.01M
Total Value
$326.77M
Institutional Holding %
74.01%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
| Institution | Shares | Ownership % | Value |
|---|---|---|---|
| BlackRock | 3.29M | 7.38% | $32.59M |
| VANGUARD | 1.72M | 3.85% | $16.99M |
| JPMorgan CHASE | 1.62M | 3.64% | $16.07M |
| DIMENSIONAL FUND | 1.58M | 3.55% | $15.67M |
| RWWM | 1.56M | 3.49% | $15.41M |
| D. E. SHAW | 1.47M | 3.28% | $14.51M |
| MILLENNIUM | 1.01M | 2.27% | $10.04M |
| MARSHALL WACE, LLP | 911.55K | 2.04% | $9.02M |
| UBS | 877.09K | 1.97% | $8.68M |
| AMERICAN CENTURY COMPANIES | 824.10K | 1.85% | $8.16M |
Recent Insider Trading
| Insider | Title | Transaction | Shares | Value | Date |
|---|---|---|---|---|---|
| Dolan Kristin A | Chief Executive Officer | A-Award | 298.37K | $- | Mar 11, 2025 |
| Kelleher Kimberly | Chief Commercial Officer | A-Award | 62.81K | $- | Mar 11, 2025 |
| Mcdermott Dan | President - Ent. & Amc Studios | A-Award | 62.81K | $- | Mar 11, 2025 |
| O'Connell Patrick | Evp & Chief Financial Officer | A-Award | 94.22K | $- | Mar 11, 2025 |
| Romanello Salvatore | Evp & General Counsel | A-Award | 50.25K | $- | Mar 11, 2025 |
| Sherin Michael J. Iii | Evp & Chief Accounting Officer | A-Award | 21.36K | $- | Mar 11, 2025 |
| Charles F. Dolan 2009 Revocable Trust | Other: Member Of 13(D) Group | S-Sale | 154.34K | $1.07M | Mar 10, 2025 |
| Charles F. Dolan 2009 Revocable Trust | Other: Member Of 13(D) Group | S-Sale | 20.83K | $143.54K | Mar 11, 2025 |
| Charles F. Dolan 2009 Revocable Trust | Other: Member Of 13(D) Group | - | $- | Dec 28, 2024 | |
| Charles F. Dolan 2009 Revocable Trust | Other: Member Of 13(D) Group | 873.13K | $- | Dec 28, 2024 |
Recent Position Changes
| Institution | Shares Changed | % Change | Date |
|---|---|---|---|
| CITADEL | -1.53M | -84.54% | Feb 14, 2025 |
| JPMorgan CHASE | +1.25M | +333.65% | Feb 12, 2025 |
| GOLDENTREE ASSET | +819.30K | +100.00% | Feb 14, 2025 |
| UBS | +742.53K | +551.86% | Feb 14, 2025 |
| JANE STREET | -656.55K | -64.57% | Feb 14, 2025 |
| +541.31K | +100.00% | Feb 11, 2025 | |
| MILLENNIUM | -509.71K | -33.46% | Feb 14, 2025 |
| EXODUSPOINT | -426.44K | -51.89% | Feb 12, 2025 |
| CHARLES SCHWAB | -395.90K | -40.43% | Feb 06, 2025 |
| JANUS HENDERSON | +297.12K | +2483.07% | Feb 14, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 15, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 12, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 11, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 11, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 11, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 11, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 11, 2025
144
Form 144 - Report of proposed sale of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 03, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Dec 12, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 23, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Oct 04, 2024
Related Metrics
Explore detailed financial metrics and analysis for AMCX.